The medications at the heart of much contemporary weight loss discussion, such as Ozempic, Wegovy, Mounjaro, and Zepbound, belong to a class of drugs known as GLP-1 receptor agonists
Women Over 40 and Perimenopausal Perimenopause introduces fluctuating estrogen levels that can make the Retatrutide response less predictable month to month
Pipeline Optionality Adds to the Bull Case Beyond the core GLP-1 franchise, Lillys pipeline is generating momentum across multiple therapeutic areas
Hosted by Bill Giebler, Content & Insights Director at New Hope Network, and Melissa Dunn, EVP of Marketing & Communications at Suzy, this webinar will explore the latest findings from Suzys consumer data and from Nutrition Business Journals research report "Supplements in the Ozempic Age." Suzys GLP-1 tracker data found that 58% of early adopters avoided sugars in their diet, while only 33% of more recent users made the same claim
only beauty products qualify
Content & Media Disclaimer Some content on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies